Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Allergy Therapeutics Plc. (OTC: AGYTF).

Full DD Report for AGYTF

You must become a subscriber to view this report.

Recent News from (OTC: AGYTF)

Allergy Therapeutics Plc. 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Allergy Therapeutics Plc. in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: March, 08 2018 13:02
Allergy Therapeutics reports 1H results
Allergy Therapeutics ( OTCPK:AGYTF ): 1H EPS of 0.99p. More news on: Allergy Therapeutics Plc., Earnings news and commentary, Consumer stocks news, , Read more ...
Source: SeekingAlpha
Date: March, 07 2018 07:13
Allergy Therapeutics Plc. 2017 Q2 - Results - Earnings Call Slides
The following slide deck was published by Allergy Therapeutics Plc. in conjunction with their 2017 Q2 earnings Read more ...
Source: SeekingAlpha
Date: September, 29 2017 13:04


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on AGYTF.

About Allergy Therapeutics Plc. (OTC: AGYTF)

Logo for Allergy Therapeutics Plc. (OTC: AGYTF)

Not available


Contact Information



    Current Share Structure

    • Market Cap: $120,579,381 - 05/11/2018
    • Issue and Outstanding: 310,771,600 - 06/30/2011


    Daily Technical Chart for (OTC: AGYTF)

    Daily Technical Chart for (OTC: AGYTF)

    Stay tuned for daily updates and more on (OTC: AGYTF)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: AGYTF)

    Do your DD and if you choose, be ready to go!


    The Research: All source information contained in this email is from the public sources mentioned below.



    Thank you

    OTC Report



    Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in AGYTF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of AGYTF and does not buy, sell, or trade any shares of AGYTF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: